James Atkinson

5PUBLICATIONS
34CO-AUTHORS
Nanoscale characterisationMolecular targetsGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 19, 2026
Publisher Correction: Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome.

Gabriel Balmus, Delphine Larrieu, Ana C Barros

|Apr 29, 2023
Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin Fixation.

Elizabeth J Wiseman, Jennifer I Moss, James Atkinson

|Aug 05, 2022
AZD4625 is a Potent and Selective Inhibitor of KRASG12C.

Atanu Chakraborty, Lyndsey Hanson, David Robinson

|Oct 08, 2020
Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs.

Nicola Colclough, Kan Chen, Peter Johnström

|Apr 29, 2018
Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome.

Gabriel Balmus, Delphine Larrieu, Ana C Barros

Pageof 1